Participation in three consecutive mass drug administrations in Leogane, Haiti

被引:34
|
作者
Mathieu, Els
Direny, Abdel N.
de Rochars, Madsen Beau
Streit, Thomas G.
Addiss, David G.
Lammie, Patrick J.
机构
[1] Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA
[2] Hop Ste Croix, Leogane, Haiti
[3] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA
关键词
lymphatic filariasis; community-based distribution; eradication; survey;
D O I
10.1111/j.1365-3156.2006.01626.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently transmission. Persons who consistently fail to participate in MDAs represent a potential threat to the goal of filariasis elimination. We wanted to know the drug coverage, the proportion of persons who were systematically noncompliant and factors associated with this behaviour. METHODS We conducted three surveys following the third annual NIDA of a filariasis elimination program in Leogane, Haiti: (1) a total population survey to determine coverage, (2) in adult survey to determine non-compliance and associated factors and (3) an urban survey to make a rural-urban comparison. RESULTS During the third MDA, the overall surveyed coverage was 78.5% [95%, confidence interval (CI) 74.4-82.6] A survey among adult population showed coverage estimates for persons > 14 years old of 59.4% (95% CI 52.0-66.7), 61.0% (95% CI 55.0-67.4) and 67.3%, (95%, CI 60.574.0), for the first, second and third MDA respectively. The coverage in rural areas (78.3%) was significantly higher than in urban areas (68.3%, P < 0.05). Of the Population > 14 years of age, 18%) never took the drugs during any of three MDAs. These persons did not differ significantly from MDA participants by age, gender or other characteristics that we assessed. CONCLUSION More research is needed to identify characteristics Of systematically non-compliant persons in order to refine health education messages and improve distribution strategies to increase drug coverage.
引用
收藏
页码:862 / 868
页数:7
相关论文
共 50 条
  • [41] OPTIMIZING HIGHLY FOCAL MASS DRUG ADMINISTRATION TARGETS FOR MALARIA ELIMINATION ACCELERATION OVER NETWORKED POPULATIONS: THE CASE OF HAITI
    Nikolov, Milen
    Battle, Katherine
    Smith, David L.
    Eckhoff, Philip A.
    Gething, Peter
    Wenger, Edward A.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 499 - 499
  • [42] RESULTS OF A PILOT OF TARGETED MASS DRUG ADMINISTRATION WITH SULFADOXINE-PYRIMETHAMINE AND PRIMAQUINE AS A COMPONENT OF A MALARIA ELIMINATION PACKAGE IN HAITI
    Chang, Michelle A.
    Impoinvil, Daniel
    Hamre, Karen E.
    Javel, Alain
    Dalexis, Paul-Emile
    Merilien, Jean-Baptiste
    Dismer, Amber M.
    Fouche, Bernadette
    Pothin, Emilie
    Battle, Katherine
    Cameron, Ewan
    Holmes, Kathleen
    Desir, Luccene
    Noland, Gregory
    Young, Alyssa
    Cohen, Justin
    Lafortune, Willy
    van den Hoogen, Lotus
    Stresman, Gillian
    Drakeley, Chris
    Rogier, Eric
    Ashton, Ruth
    Druetz, Thomas
    Eisele, Thomas P.
    Lemoine, Jean Frantz
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 417 - 417
  • [43] SAFETY AND EFFICACY OF CO-ADMINISTERED DIETHYLCARBAMZINE, ALBENDAZOLE AND IVERMECTION DURING MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS IN HAITI
    Dubray, Christine
    Sircar, Anita
    de Rochars, Madsen
    Bogus, Joshua
    Direny, Abdel
    Ernest, Jean
    Fayette, Carl
    O'Brian, Katiuscia
    Pavilus, Guy
    Sabin, Daniel
    Wiegand, Ryan
    Weil, Gary
    Lemoine, Jean
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 1 - 1
  • [44] DECLINING MASS DRUG ADMINISTRATION COVERAGE FOR LYMPHATIC FILARIASIS IN PORT-AU-PRINCE, HAITI: A PROGRAMMATIC CASE STUDY AND RECOMMENDATIONS
    Wodnik, Breanna K.
    Louis, Didie H.
    Joseph, Michel
    Wilkers, Lee T.
    Landskroener, Susan D.
    Lemoine, Jean F.
    Lavery, James V.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 400 - 400
  • [45] Characterization of Three Pleiotropic Drug Resistance Transporter Genes and Their Participation in the Azole Resistance of Mucor circinelloides
    Nagy, Gabor
    Kiss, Sandor
    Varghese, Rakesh
    Bauer, Kitti
    Szebenyi, Csilla
    Kocsube, Sandor
    Homa, Monika
    Bodai, Laszlo
    Zsindely, Nora
    Nagy, Gabor
    Vagvolgyi, Csaba
    Papp, Tamas
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [46] Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular Degeneration
    Hosoda, Shuhei
    Sakurada, Yoichi
    Fukuda, Yoshiko
    Kotoda, Yumi
    Kikushima, Wataru
    Kashiwagi, Kenji
    PHARMACEUTICALS, 2025, 18 (03)
  • [47] Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar
    Dickson, Benjamin F. R.
    Graves, Patricia M.
    Aye, Ni Ni
    Nwe, Thet Wai
    Wai, Tint
    Win, San San
    Shwe, Myint
    Douglass, Janet
    Wood, Peter
    Wangdi, Kinley
    McBride, William J.
    PARASITES & VECTORS, 2021, 14 (01)
  • [48] Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar
    Benjamin F. R. Dickson
    Patricia M. Graves
    Ni Ni Aye
    Thet Wai Nwe
    Tint Wai
    San San Win
    Myint Shwe
    Janet Douglass
    Peter Wood
    Kinley Wangdi
    William J. McBride
    Parasites & Vectors, 14
  • [49] Cost comparison of three strategies to target drug eluting stent (DES) costs in 617 consecutive patients undergoing PCI
    Irving, RJ
    Sulfi, S
    Moffitt, A
    Sutton, AGC
    Wright, RA
    Harcombe, AA
    Hall, JA
    de Belder, MA
    HEART, 2004, 90 : A18 - A19
  • [50] Safety of Ommaya reservoirs in children with brain tumors: Experience with 2,213 intraventricular drug administrations in 58 consecutive patients treated at the medical university of Vienna (1992-2007)
    Slavc, Irene
    Gruber-Olipitz, Mariella
    Minichmayr, Elke
    Peyrl, Andreas
    Azizi, Amedeo
    Czech, Thomas
    NEURO-ONCOLOGY, 2008, 10 (03) : 446 - 446